Prion protein self-peptides modulate prion interactions and conversion

BMC Biochemistry

Volumn 10, Issue 1, 2009, Pages

  Rigter, Alan ^a   Priem, Jan ^a   Timmers Parohi, Drophatie ^b   Langeveld, Jan P M ^a   Van Zijderveld, Fred G ^a   Bossers, Alex ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Pepscan Presto BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PEPTIDE DERIVATIVE; PRION PROTEIN; PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN HOMOGENATE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; NONHUMAN; PRION DISEASE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; SCRAPIE; SCRAPIE AGENT; SPECIES DIFFERENCE; VIRUS REPLICATION; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE; SHEEP;

OVIS;

AMINO ACID MOTIFS; ANIMALS; PEPTIDES; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; PRPC PROTEINS; PRPSC PROTEINS; SHEEP;

EID: 72849109559     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-10-29     Document Type: Article

References (77)

1. Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment. SJ DeArmond SB Prusiner, Clin Lab Med 2003 23 1 1 41
2. In vitro conversion of normal prion protein into pathologic isoforms. A Bossers A Rigter R de Vries MA Smits, Clin Lab Med 2003 23 1 227 247
3. Evidence for assembly of prions with left-handed beta-helices into trimers. C Govaerts H Wille SB Prusiner FE Cohen, Proc Natl Acad Sci USA 2004 101 22 8342 8347
4. Two-rung Model of a Left-handed beta-Helix for Prions Explains Species Barrier and Strain Variation in Transmissible Spongiform Encephalopathies. JP Langedijk G Fuentes R Boshuizen AM Bonvin, J Mol Biol 2006 360 4 907 920
5. Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. A Bossers R de Vries MA Smits, J Virol 2000 74 3 1407 1414
6. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. DA Kocisko SA Priola GJ Raymond B Chesebro PT Lansbury Jr B Caughey, Proc Natl Acad Sci USA 1995 92 9 3923 3927
7. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. J Castilla P Saa R Morales K Abid K Maundrell C Soto, Methods Enzymol 2006 412 3 21 (Pubitemid 44548570)
8. Detection of prions in blood. J Castilla P Saa C Soto, Nat Med 2005 11 9 982 985
9. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. GP Saborio B Permanne C Soto, Nature 2001 411 6839 810 813
10. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. C Soto L Anderes S Suardi F Cardone J Castilla MJ Frossard S Peano P Saa L Limido M Carbonatto, et al. FEBS Lett 2005 579 3 638 642
11. Multiplicative genetic effects in scrapie disease susceptibility. MA Dubois P Sabatier B Durand D Calavas C Ducrot K Chalvet-Monfray, C R Biol 2002 325 5 565 570
12. Influence of the prion protein gene, Prnp, on scrapie susceptibility in sheep. MA Tranulis, Apmis 2002 110 1 33 43
13. PrP polymorphisms tightly control sheep prion replication in cultured cells. E Sabuncu S Petit A Le Dur T Lan Lai JL Vilotte H Laude D Vilette, J Virol 2003 77 4 2696 2700
14. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion. A Rigter A Bossers, J Gen Virol 2005 86 Pt 9 2627 2634
15. Mapping of possible prion protein self interaction domains using peptide arrays. A Rigter JP Langeveld D Timmers-Parohi JG Jacobs PL Moonen A Bossers, BMC Biochem 2007 8 1 6
16. Cell-surface prion protein interacts with glycosaminoglycans. T Pan BS Wong T Liu R Li RB Petersen MS Sy, Biochem J 2002 368 Pt 1 81 90
17. Prion protein expression aids cellular uptake and veratridine-induced release of copper. DR Brown, J Neurosci Res 1999 58 5 717 725
18. Role of the prion protein in copper turnover in astrocytes. DR Brown, Neurobiol Dis 2004 15 3 534 543
19. Antioxidant activity related to copper binding of native prion protein. DR Brown C Clive SJ Haswell, J Neurochem 2001 76 1 69 76
20. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis. L Dupuis C Mbebi JL Gonzalez de Aguilar F Rene A Muller M de Tapia JP Loeffler, Mol Cell Neurosci 2002 19 2 216 224
21. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. E Flechsig D Shmerling I Hegyi AJ Raeber M Fischer A Cozzio C von Mering A Aguzzi C Weissmann, Neuron 2000 27 2 399 408
22. Influence of the N-terminal domain on the aggregation properties of the prion protein. KN Frankenfield ET Powers JW Kelly, Protein Sci 2005 14 8 2154 2166
23. Imbalance of antioxidant defense in mice lacking cellular prion protein. F Klamt F Dal-Pizzol MJ Conte da Frota R Walz ME Andrades EG da Silva RR Brentani I Izquierdo JC Fonseca Moreira, Free Radic Biol Med 2001 30 10 1137 1144
24. Ablation of cellular prion protein expression affects mitochondrial numbers and morphology. G Miele M Jeffrey D Turnbull J Manson M Clinton, Biochem Biophys Res Commun 2002 291 2 372 377
25. Copper stimulates endocytosis of the prion protein. PC Pauly DA Harris, J Biol Chem 1998 273 50 33107 33110
26. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. W Rachidi D Vilette P Guiraud M Arlotto J Riondel H Laude S Lehmann A Favier, J Biol Chem 2003 278 11 9064 9072
27. Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. A Sakudo DC Lee K Saeki Y Nakamura K Inoue Y Matsumoto S Itohara T Onodera, Biochem Biophys Res Commun 2003 308 3 660 667
28. Increased sensitivity to seizures in mice lacking cellular prion protein. R Walz OB Amaral IC Rockenbach R Roesler I Izquierdo EA Cavalheiro VR Martins RR Brentani, Epilepsia 1999 40 12 1679 1682
29. Differential contribution of superoxide dismutase activity by prion protein in vivo. BS Wong T Pan T Liu R Li P Gambetti MS Sy, Biochem Biophys Res Commun 2000 273 1 136 139
30. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. E Wong AM Thackray R Bujdoso, Biochem J 2004 380 Pt 1 273 282
31. Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress. F Zeng NT Watt AR Walmsley NM Hooper, J Neurochem 2003 84 3 480 490
32. Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe. JG Jacobs JP Langeveld AG Biacabe PL Acutis MP Polak D Gavier-Widen A Buschmann M Caramelli C Casalone M Mazza, et al. J Clin Microbiol 2007 45 6 1821 1829
33. Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein. CM Thuring JH Erkens JG Jacobs A Bossers LJ Van Keulen GJ Garssen FG Van Zijderveld SJ Ryder MH Groschup T Sweeney, et al. J Clin Microbiol 2004 42 3 972 980
34. Enhanced stability of human prion proteins with two disulfide bridges. TP Knowles R Zahn, Biophys J 2006 91 4 1494 1500
35. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. C Korth B Stierli P Streit M Moser O Schaller R Fischer W Schulz-Schaeffer H Kretzschmar A Raeber U Braun, et al. Nature 1997 390 6655 74 77
36. Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse. T Kuczius J Grassi H Karch MH Groschup, Febs J 2007 274 6 1492 1502
37. Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. F Martucci P Acutis M Mazza S Nodari S Colussi C Corona S Barocci A Gabrielli M Caramelli C Casalone, et al. J Gen Virol 2009
38. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. G Moroncini N Kanu L Solforosi G Abalos GC Telling M Head J Ironside JP Brockes DR Burton RA Williamson, Proc Natl Acad Sci USA 2004 101 28 10404 10409
39. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. G Moroncini M Mangieri M Morbin G Mazzoleni B Ghetti A Gabrielli RA Williamson G Giaccone F Tagliavini, Neurobiol Dis 2006 23 3 717 724
40. A prion protein epitope selective for the pathologically misfolded conformation. E Paramithiotis M Pinard T Lawton S LaBoissiere VL Leathers WQ Zou LA Estey J Lamontagne MT Lehto LH Kondejewski, et al. Nat Med 2003 9 7 893 899
41. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. M Horiuchi GS Baron LW Xiong B Caughey, J Biol Chem 2001 276 18 15489 15497
42. Toward Molecular Dissection of PrPC-PrPSc Interactions. L Solforosi A Bellon M Schaller JT Cruite GC Abalos RA Williamson, J Biol Chem 2007 282 10 7465 7471
43. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. C Soto GP Saborio L Anderes, Trends Neurosci 2002 25 8 390 394
44. Structural studies of the scrapie prion protein by electron crystallography. H Wille MD Michelitsch V Guenebaut S Supattapone A Serban FE Cohen DA Agard SB Prusiner, Proc Natl Acad Sci USA 2002 99 6 3563 3568
45. Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. AC Apetri K Maki H Roder WK Surewicz, J Am Chem Soc 2006 128 35 11673 11678
46. The effect of disease-associated mutations on the folding pathway of human prion protein. AC Apetri K Surewicz WK Surewicz, J Biol Chem 2004 279 17 18008 18014
47. Oligomerization of the human prion protein proceeds via a molten globule intermediate. R Gerber A Tahiri-Alaoui PJ Hore W James, J Biol Chem 2007 282 9 6300 6307
48. Conformational properties of beta -PrP. LL Hosszu CR Trevitt S Jones M Batchelor DJ Scott GS Jackson J Collinge JP Waltho AR Clarke, J Biol Chem 2009
49. The elusive intermediate on the folding pathway of the prion protein. DC Jenkins ID Sylvester TJ Pinheiro, Febs J 2008 275 6 1323 1335
50. Mechanisms of prion protein assembly into amyloid. J Stohr N Weinmann H Wille T Kaimann L Nagel-Steger E Birkmann G Panza SB Prusiner M Eigen D Riesner, Proc Natl Acad Sci USA 2008 105 7 2409 2414
51. A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. TA Campbell MS Palmer RG Will WR Gibb PJ Luthert J Collinge, Neurology 1996 46 3 761 766
52. Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation. EJ Cochran DA Bennett L Cervenakova K Kenney B Bernard NL Foster DF Benson LG Goldfarb P Brown, Neurology 1996 47 3 727 733 (Pubitemid 26307304)
53. A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt-Jakob disease. LG Goldfarb P Brown BW Little L Cervenakova K Kenney CJ Gibbs Jr DC Gajdusek, Neurology 1993 43 11 2392 2394
54. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. LG Goldfarb P Brown WR McCombie D Goldgaber GD Swergold PR Wills L Cervenakova H Baron CJ Gibbs Jr DC Gajdusek, Proc Natl Acad Sci USA 1991 88 23 10926 10930
55. Two novel insertions in the prion protein gene in patients with late-onset dementia. JL Laplanche N Delasnerie-Laupretre JP Brandel M Dussaucy J Chatelain JM Launay, Hum Mol Genet 1995 4 6 1109 1111
56. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro. VA Lawson SA Priola K Meade-White M Lawson B Chesebro, J Biol Chem 2004 279 14 13689 13695
57. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. C Hundt JM Peyrin S Haik S Gauczynski C Leucht R Rieger ML Riley JP Deslys D Dormont CI Lasmezas, et al. Embo J 2001 20 21 5876 5886 (Pubitemid 33049263)
58. Self-aggregation of reverse bis peptide conjugate derived from the unstructured region of the prion protein. C Madhavaiah S Verma, Chem Commun (Camb) 2004 6 638 639
59. Prion Disease: Susceptibility and Transmissibility; In vivo and in vitro studies with sheep scrapie. A Bossers, PhD. University of Utrecht 1999
60. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms. A Bossers P Belt GJ Raymond B Caughey R de Vries MA Smits, Proc Natl Acad Sci USA 1997 94 10 4931 4936
61. PrP genotype contributes to determining survival times of sheep with natural scrapie. A Bossers BE Schreuder IH Muileman PB Belt MA Smits, J Gen Virol 1996 77 Pt 10 2669 2673
62. PrP genotypes and the Sip gene in Cheviot sheep form the basis for scrapie strain typing in sheep. W Goldmann N Hunter G Smith J Foster J Hope, Ann N Y Acad Sci 1994 724 296 299
63. Natural scrapie in a closed flock of Cheviot sheep occurs only in specific PrP genotypes. N Hunter JD Foster W Goldmann MJ Stear J Hope C Bostock, Arch Virol 1996 141 5 809 824
64. The emerging principles of Mammalian prion propagation and transmissibility barriers: insight from studies in vitro. WK Surewicz EM Jones AC Apetri, Acc Chem Res 2006 39 9 654 662
65. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. C Wong LW Xiong M Horiuchi L Raymond K Wehrly B Chesebro B Caughey, Embo J 2001 20 3 377 386
66. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Chabry B Caughey B Chesebro, J Biol Chem 1998 273 21 13203 13207 (Pubitemid 28246891)
67. Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence. J Chabry SA Priola K Wehrly J Nishio J Hope B Chesebro, J Virol 1999 73 8 6245 6250
68. Putative aggregation initiation sites in prion protein. J Ziegler C Viehrig S Geimer P Rosch S Schwarzinger, FEBS Lett 2006 580 8 2033 2040
69. Sonication induced sheet formation at the air-water interface. KS Satheeshkumar R Jayakumar, Chem Commun (Camb) 2002 2244 2245
70. The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment. CJ Bosques B Imperiali, Proc Natl Acad Sci USA 2003 100 13 7593 7598
71. Immunohistochemical detection and localization of prion protein in brain tissue of sheep with natural scrapie. LJ van Keulen BE Schreuder RH Meloen M Poelen-van den Berg G Mooij-Harkes ME Vromans JP Langeveld, Vet Pathol 1995 32 3 299 308
72. Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. W Goldmann N Hunter T Martin M Dawson J Hope, J Gen Virol 1991 72 Pt 1 201 204
73. Mapping functional prion-prion protein interaction sites using prion protein based peptide-arrays. A Rigter J Priem D Timmers-Parohi JP Langeveld A Bossers, Methods Mol Biol 2009 570 257 271
74. Cellular prion protein status in sheep: tissue-specific biochemical signatures. M Moudjou Y Frobert J Grassi C La Bonnardiere, J Gen Virol 2001 82 Pt 8 2017 2024
75. Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep. JP Langeveld JG Jacobs JH Erkens A Bossers FG van Zijderveld LJ van Keulen, BMC Vet Res 2006 2 19
76. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. S Harmeyer E Pfaff MH Groschup, J Gen Virol 1998 79 Pt 4 937 945
77. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. C Feraudet N Morel S Simon H Volland Y Frobert C Creminon D Vilette S Lehmann J Grassi, J Biol Chem 2005 280 12 11247 11258